Key result
Stem cell-derived cardiomyocytes are discussed as a potential tool for studying proarrhythmia and screening new drug candidates for IKr blocking potency and QT prolongation risk.
Highlights the role of stem cell-derived cardiomyocytes as a tool for screening new drug candidates for proarrhythmic potential and QT prolongation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Roden et al. (2013) conducted a review in Proarrhythmia. Stem Cell-Derived Cardiomyocytes was evaluated. Stem cell-derived cardiomyocytes are discussed as a potential tool for studying proarrhythmia and screening new drug candidates for IKr blocking potency and QT prolongation risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: